Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

C4 Therapeutics (CCCC) Other Non Operating Income (2019 - 2023)

C4 Therapeutics (CCCC) has 2 years of Other Non Operating Income data on record, last reported at $21000.0 in Q4 2023.

  • For Q4 2023, Other Non Operating Income changed N/A year-over-year to $21000.0; the TTM value through Dec 2024 reached -$579000.0, changed 0.17%, while the annual FY2023 figure was -$600000.0, N/A changed from the prior year.
  • Other Non Operating Income reached $21000.0 in Q4 2023 per CCCC's latest filing, up from -$600000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $21000.0 in Q4 2023 and bottomed at -$600000.0 in Q3 2023.